FinTrust Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-67
| Closed | -$8K | – | 1199 |
|
|
2020
Q2 | $8K | Sell |
67
-270
| -80% | -$32.2K | ﹤0.01% | 764 |
|
|
2020
Q1 | $30K | Sell |
337
-301
| -47% | -$26.8K | 0.01% | 538 |
|
|
2019
Q4 | $69K | Sell |
638
-3,694
| -85% | -$400K | 0.03% | 386 |
|
|
2019
Q3 | $424K | Buy |
4,332
+336
| +8% | +$32.9K | 0.14% | 118 |
|
|
2019
Q2 | $524K | Buy |
3,996
+3,549
| +794% | +$465K | 0.21% | 104 |
|
|
2019
Q1 | $60K | Buy |
+447
| New | +$60K | 0.03% | 354 |
|